Shandong Xinhua Pharmaceutical Schedules Board Meeting to Approve 1H26 Interim Results

Bulletin Express08-11 17:09

Shandong Xinhua Pharmaceutical Company Limited will convene its board of directors at 9:30 a.m. on 25 August 2026 in the company’s conference room at No. 1 Lutai Avenue, Hi-tech District, Zibo, Shandong, China.

The primary agenda is to review and approve the unaudited interim financial results of the company and its subsidiaries for the six months ended 30 June 2026. The board may also address other business matters during the session.

The board currently consists of Executive Directors He Tongqing (Chairman), Xu Wenhui and Hou Ning; Independent Non-executive Directors Pan Guangcheng, Zhu Jianwei, Ling Peixue and Cheung Ching Ching, Daisy; and Non-executive Director Zhang Chengyong.

The notice was issued by Chairman He Tongqing on 11 August 2026 in Zibo, Shandong.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment